semaglutide compounding fda enforcement news Crackdown on Compounded GLP-1 Drugs semaglutide Archives | American College

A 2023 analysis of semaglutide users with pre-existing bowel disorders found that 78% maintained or improved their IBS symptom scores after 12 weeks, provided they started at the lowest dose and titrated gradually

Oral Contraceptives: Tirzepatide (Zepbound/Mounjaro) may reduce efficacy due to slowed gastric emptying, especially during initiation and escalation

Coverage for GLP-1 weight loss therapy in non-diabetic patients is improving but still varies

By boosting collagen and elastin, they contribute to visibly firmer, more elastic skin

However, the role of GSSG accumulation in the vacuoles and plastids remains to be investigated

The biggest unknowns about medications in this category are long-term implications of teenagers (and adults) using GLP-1s